index - Myopathies inflammatoires & thérapies innovantes ciblées

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Skeletal muscle Anémie hémolytique Systems biology Fabry disease Antisynthétase Data integration AAV humoral immunity Inborn errors of metabolism Inflammatory myopathy Interferon Adeno-associated virus Adult Aged Antibodies Anticorps spécifique des myosites Inclusion body myositis Agalsidase Auto-immunité Biopsy COVID-19 Immune checkpoint inhibitors Autoimmunity AAV vectors Immunotherapy Myositis Anti-interleukin-6 Anti-Mi2 AAV AAV antibody Cardio-oncology Pharmacology Adeno-associated vector Polymyositis Dependovirus/genetics/immunology Female Adeno-associated virus vector Outcome measures Deep immune profiling Adverse drug reactions Myocarditis Assisted communication devices Analyses multidimensionnelles Antiphospholipid syndrome Antisynthetase Auto‐antibodies Biomarkers Inflammation Adjudication Anticorps anti-agalsidase Autoantibody Arthritis Bioelectrical impedance analysis Interstitial lung disease Cancer B-lymphocyte Idiopathic inflammatory myopathies Dermatomyositis Anti-IgE IgG IBM Active Adolescence Cytokines Abnormal movement Machine learning Anti‐mitochondrial antibodies Case reports Aldostérone DM Acid-alpha-glucosidase Aldosterone Biomarqueurs Myopathy Antisynthetase syndrome Lysosomal storage diseases Middle Aged Acute Kidney Injury/epidemiology/etiology Anti-drug antibodies Humans IMNM Autoimmune diseases Male Sphingosine-1-phosphate Myositis and muscle disease Prognosis Gene therapy Mass cytometry Amyotrophy Multidisciplinarity Muscle Antibody responses Animals Amyotrophic lateral sclerosis Anti-MDA5 autoantibodies Biomarker Anti-synthetase syndrome Auto-antibodies Anti-agalsidase antibodies B cell homeostasis Autoantibodies AAV vector